Alzheimer’s drug may benefit some patients, new data shows
Dr. Thambisetty said the two deaths raise questions about the safety issues of lecanemab “in real-world clinical practice, where patients are more likely to be… Read More »Alzheimer’s drug may benefit some patients, new data shows